<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-13-52906</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0091522</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Genetics</subject><subj-group><subject>Heredity</subject><subj-group><subject>Genotypes</subject></subj-group></subj-group><subj-group><subject>Human genetics</subject><subj-group><subject>Genetic testing</subject></subj-group></subj-group><subj-group><subject>Population genetics</subject><subj-group><subject>Genetic polymorphism</subject></subj-group></subj-group></subj-group><subj-group><subject>Population biology</subject><subj-group><subject>Population genetics</subject><subj-group><subject>Genetic polymorphism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Clinical genetics</subject></subj-group><subj-group><subject>Critical care and emergency medicine</subject><subj-group><subject>Sepsis</subject></subj-group></subj-group><subj-group><subject>Epidemiology</subject><subj-group><subject>Clinical epidemiology</subject><subject>Genetic epidemiology</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Autophagy-Related <italic>IRGM</italic> Polymorphism Is Associated with Mortality of Patients with Severe Sepsis</article-title>
<alt-title alt-title-type="running-head">Association between <italic>IRGM</italic> SNP and Severe Sepsis</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kimura</surname><given-names>Tomonori</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Watanabe</surname><given-names>Eizo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sakamoto</surname><given-names>Teruo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Takasu</surname><given-names>Osamu</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ikeda</surname><given-names>Toshiaki</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ikeda</surname><given-names>Kazumi</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kotani</surname><given-names>Joji</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kitamura</surname><given-names>Nobuya</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sadahiro</surname><given-names>Tomohito</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tateishi</surname><given-names>Yoshihisa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Shinozaki</surname><given-names>Koichiro</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Oda</surname><given-names>Shigeto</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chu-ku, Chiba City, Chiba, Japan</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Department of Emergency and Critical Care Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume City, Fukuoka, Japan</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Division of Critical Care and Emergency Medicine, Tokyo Medical University Hachioji Medical Center, 1163 Tate-machi, Hachioji City, Tokyo, Japan</addr-line></aff>
<aff id="aff4"><label>4</label><addr-line>Department of Emergency, Disaster and Critical Care Medicine, Hyogo College of Medicine, 1-1, Mukogawa-cho, Nishinomiya City, Hyogo, Japan</addr-line></aff>
<aff id="aff5"><label>5</label><addr-line>Department of Emergency and Critical Care Medicine, Kimitsu Chuo Hospital, 1010 Sakurai, Kisarazu City, Chiba, Japan</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Salluh</surname><given-names>Jorge I. F.</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>D’or Institute of Research and Education, Brazil</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">watanabee@faculty.chiba-u.jp</email></corresp>
<fn fn-type="conflict"><p>ZENKYOREN provided funding towards this study (EW). There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: EW SO. Performed the experiments: TK. Analyzed the data: TK EW T. Sadahiro YT KS. Contributed reagents/materials/analysis tools: T. Sakamoto OT TI KI JK NK. Wrote the paper: TK EW.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>13</day><month>3</month><year>2014</year></pub-date>
<volume>9</volume>
<issue>3</issue>
<elocation-id>e91522</elocation-id>
<history>
<date date-type="received"><day>19</day><month>12</month><year>2013</year></date>
<date date-type="accepted"><day>11</day><month>2</month><year>2014</year></date>
</history>
<permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>Kimura et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract><sec>
<title>Objective</title>
<p>Autophagy is the regulated catabolic process for recycling damaged or unnecessary organelles, which plays crucial roles in cell survival during nutrient deficiency, and innate immune defense against pathogenic microorganisms. Autophagy has been also reported to be involved in various conditions including inflammatory diseases. <italic>IRGM</italic> (human immunity-related GTPase) has an important function in eliminating <italic>Mycobacterium tuberculosis</italic> from host cells <italic>via</italic> autophagy. We examined the association between genetic polymorphism and clinical course/outcome in severely septic patients.</p>
</sec><sec>
<title>Methods</title>
<p>The study included 125 patients with severe sepsis/septic shock (SS) and 104 non-sepsis patients who were admitted to the intensive care unit (ICU) of Chiba University Hospital between October 2001 and September 2008 (discovery cohort) and 268 SS patients and 454 non-sepsis patients who were admitted to ICUs of five Japanese institutions including Chiba University Hospital between October 2008 and September 2012 (multi-center validation cohort). Three hundred forty seven healthy volunteers who consented to this study were also included. Genotyping was performed for a single-nucleotide polymorphism (SNP) within the coding region of <italic>IRGM</italic>, IRGM(+313) (rs10065172). Lipopolysaccharide challenge of whole blood from randomly selected healthy volunteers (n = 70) was performed for comparison of <italic>IRGM</italic> mRNA expression among different genotypes.</p>
</sec><sec>
<title>Results</title>
<p>No significant difference in genotypic distributions (CC/CT/TT) at the IRGM(+313) locus was observed among the three subject groups (SS, non-sepsis, and healthy volunteers) in either cohort. When mortality were compared, no significant difference was observed in the non-sepsis group, while TT homozygotes exhibited a significantly higher mortality than the CC+CT genotype category in the SS group for both cohorts (<italic>P</italic> = 0.043, 0.037). Lipopolysaccharide challenge to whole blood showed a significant suppression of <italic>IRGM</italic> mRNA expression in TT compared with the CC+CT genotype category (<italic>P</italic> = 0.019).</p>
</sec><sec>
<title>Conclusions</title>
<p>The data suggest that the IRGM(+313), an autophagy-related polymorphic locus, influences outcome in severely septic patients, with the possible involvement of autophagy in sepsis exacerbation.</p>
</sec></abstract>
<funding-group><funding-statement>This work was supported by the Grants-in-Aid for Young Scientists (B) of Grants-in-Aid for Scientific Research (#23792070) from the Ministry of Education, Culture, Sports Science, and Technology, Japan (TK). This work was also supported by ZENKYOREN (EW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="8"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Severe sepsis is the host inflammatory response to infection with presence of organ dysfunction <xref ref-type="bibr" rid="pone.0091522-Vincent1">[1]</xref>. It is a critical condition that is very difficult to survive, as indicated by high mortality rates ranging from 30% and 80% in various countries <xref ref-type="bibr" rid="pone.0091522-Beale1">[2]</xref>, <xref ref-type="bibr" rid="pone.0091522-Silva1">[3]</xref>. After overcoming the acute inflammatory response phase and remission of SIRS, septic patients go into an anti-inflammatory phase, which is even more difficult to overcome (CARS; compensatory anti-inflammatory response syndrome). The subsequent development of immunoparalysis is believed to affect the prognosis of sepsis, particularly during the post-acute phase <xref ref-type="bibr" rid="pone.0091522-Hotchkiss1">[4]</xref>–<xref ref-type="bibr" rid="pone.0091522-Boomer1">[6]</xref>.</p>
<p>Apoptosis (type I programmed cell death) of immune effector cells plays a crucial role in the pathophysiology of CARS and immunoparalysis in sepsis, and the regulation of apoptosis is expected to improve survival in sepsis <xref ref-type="bibr" rid="pone.0091522-Hotchkiss2">[7]</xref>, <xref ref-type="bibr" rid="pone.0091522-Hotchkiss3">[8]</xref>. On the other hand, the involvement of autophagy (type II programmed cell death) in the pathophysiology of sepsis has attracted the attention of both researchers and clinicians <xref ref-type="bibr" rid="pone.0091522-Crouser1">[9]</xref>–<xref ref-type="bibr" rid="pone.0091522-Watanabe1">[11]</xref>. Autophagy (“self-eating”), a regulated catabolic process, has roles in the degradation of unnecessary organelles, elimination of pathogenic microorganisms, and tumor suppression <xref ref-type="bibr" rid="pone.0091522-Choi1">[12]</xref>. Sepsis-induced organ failure is considered to be the summation of cellular dysfunction induced by cell death of different cells <xref ref-type="bibr" rid="pone.0091522-Oda1">[13]</xref>, and vital organ failure may be related to immune system abnormalities. Recently, the genome-wide association study (GWAS) approach has enabled systematic searches of disease susceptibility genes. Using this methodology, an autophagy-related gene, autophagy-related protein 16-like 1 (<italic>ATG16L1</italic>), was identified as a disease susceptibility gene closely involved in the pathophysiology of Crohn’s disease, an inflammatory bowel disease <xref ref-type="bibr" rid="pone.0091522-Hampe1">[14]</xref>. In addition, an association between IRGM (a human immunity-related GTPase) expression and the induction and execution of autophagy upon bacterial infections, such as tuberculosis, has been reported with regulation of autophagy formation in proportion to IRGM expression <xref ref-type="bibr" rid="pone.0091522-Singh1">[15]</xref>. Furthermore, genetic polymorphism of <italic>IRGM</italic> has been confirmed to be involved in the development of inflammatory bowel disease and in the induction of autophagy <xref ref-type="bibr" rid="pone.0091522-Amre1">[16]</xref>.</p>
<p>To investigate how autophagy is involved in the pathophysiology of severe sepsis/septic shock, <italic>i.e.</italic>, a highly systemic inflammatory disease, we examined the association between a single-nucleotide polymorphism (SNP) in the autophagy-related IRGM gene and clinical outcomes in severe sepsis for two cohorts (one single-center cohort and one multi-center cohort) in Japanese population. We also examined the mRNA expression of autophagy-related SNP under stimulus by lipopolysaccharide (LPS) <italic>ex vivo</italic>.</p>
</sec><sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2a">
<title>1. Discovery Cohort</title>
<p>The protocol was approved by institutional Ethic Committees at all the 5 participating institutes (the Ethics Committee of Chiba University School of Medicine (permission number 205), the Ethical Committee of Kurume University (bioethics permission number 49), the Medical Research Ethics Committee of Tokyo Medical University, the Ethics Review Board of Hyogo College of Medicine, and the Ethics Committee of Kimitsu Chuo Hospital). After approval by the institutional ethics committees, written informed consent from patients or their next of kin was obtained. In discovery cohort, 259 critically ill patients admitted to the general intensive care unit (ICU) of Chiba university hospital in Chiba, Japan, between October 2001 and September 2008. Inclusion criteria were admitted to the ICU, 18 years of age or older, patients capable of obtaining informed consent in writing own, family, or the legal representative. Exclusion criteria included pregnancy, treatment in the hematologic malignancies, patients receiving radiation treatment and chemotherapy, history of genetic therapy, and outside the scope of active treatment. Blood samples were obtained immediately after admission to the ICU. Centrifuged blood samples were kept separate blood cells and serum at −80°C. The genomic DNA was extracted from whole blood cells.</p>
</sec><sec id="s2b">
<title>2. Multi-center Validation Cohort</title>
<p>In multi-center validation cohort, 793 critically ill patients admitted to the five general ICU including the five tertiary medical centers, or Kurume University Hospital, Tokyo Medical University Hachioji Medical Center, Hyogo College of Medicine, Kimitsu Chuo Hospital and Chiba University Hospital from October 2008 to September 2012. Inclusion and exclusion criteria were the same as the discovery cohort. On admission at the ICUs, blood samples were obtained. The blood cells were refrigerated and collected to Chiba University Hospital, and the genomic DNA was thereafter extracted.</p>
</sec><sec id="s2c">
<title>3. Data Collection</title>
<p>Baseline characteristics (age, gender), as well as clinical data including length of ICU stay, Sequential Organ failure Assessment (SOFA) scores <xref ref-type="bibr" rid="pone.0091522-Vincent2">[17]</xref>, Acute Physiology and Chronic Health Evaluation (APACHE) II scores <xref ref-type="bibr" rid="pone.0091522-Knaus1">[18]</xref>, morbidity of severe sepsis and septic shock, ICU mortality were obtained after the patients were documented at study entry. The APACHE II scores and SOFA scores were calculated in the first 24 hours after admission.</p>
<p>The diagnosis of systemic inflammatory response syndrome (SIRS) and sepsis, severe sepsis and septic shock were based on the criteria presented at the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference in 1992 <xref ref-type="bibr" rid="pone.0091522-1">[19]</xref>. In the present study, both severe sepsis and septic shock is expressed together as SS group.</p>
</sec><sec id="s2d">
<title>4. IRGM(+313) (rs10065172) Genotyping</title>
<p>Genomic DNA was extracted from ethylenediaminetetraacetic acid anticoagulated blood using Qiagen’s QIAamp DNA Minikit (Qiagen, Valencia, CA) according to manufacturer’s instructions. We amplified the target region of DNA by polymerase chain reaction (PCR) with primers (Applied Biosystems, Foster City, CA) specific for the sequence of IRGM(+313) (rs10065372), a SNP which presents at the position of +313 inside the exon 2 of <italic>IRGM</italic> in the chromosome 5q33.1 <xref ref-type="bibr" rid="pone.0091522-Parkes1">[20]</xref>, <xref ref-type="bibr" rid="pone.0091522-Prescott1">[21]</xref>. Each 25 µL of PCR mixture contained 20 ng of genomic DNA, 900 nM primers, 250 nM probes, and 12.5 µL of TaqMan Universal PCR master mix (Applied Biosystems, Foster City, CA), which is a solution containing buffer, uracil-N-glycosylase, deoxyribonucleotides, uridine, passive reference dye (ROX), and TadGold DNA polymerase. Amplification was done under the following conditions: 50°C for 2 min, 95°C for 10 min, and 40 cycles at 92°C for 15 sec and 60°C for 1 min. Fluorescence in each well was measured before and after PCR using an ABI PRISM 7000 Sequence Detection System (Applied Biosystems, Foster City, CA).</p>
</sec><sec id="s2e">
<title>5. <italic>IRGM</italic> mRNA Expression <italic>ex vivo</italic></title>
<p>The subjects were 347 healthy volunteers who consented to this study. Extraction of genomic DNA and <italic>IRGM</italic> polymorphisms were analyzed by the method described above.</p>
<p>The randomly selected 70 healthy volunteers, whole blood mixed 10 mL:10 mL with cell culture medium (RPMI 1640 (Wako, Tokyo, Japan)) were transferred to 12-well microtiter plates (Falcon, Mountain View, CA). Samples were incubated at 37°C and 5% CO<sub>2</sub> with endotoxin (lipopolysaccharide, 1 ng/mL; from <italic>Salmonella friedenau</italic>) for 4 hours. Control mixtures were incubated without endotoxin. After incubation, the supernatants were separated and stored frozen at −80°C. 300 µL of the RNA Protect Cell Reagent (Qiagen, Valencia, CA) was added to the blood cell component after centrifugation, and the mixture was stored at −80°C. Each mRNA was extracted using QIAamp RNA Blood Mini Kit (Qiagen, Valencia, CA) from the blood cells. The mRNA was reversed transcribed into complementary DNA (cDNA) using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA) according to the manufacturer’s instructions. Real-time PCR with specific fluorescence-labeled probe was used to quantify mRNA expression of <italic>IRGM</italic>. The reaction was performed in 96-well microtiter plates with an ABI PRISM 7000 Sequence Detection System. Primers (glyceraldehyde-3-phosphate dehydrogenase; Assay ID: Hs03929097_g1, Applied Biosystems, Foster City, CA) and regents were purchased from Applied Biosystems Inc. PCR reactions were performed in a total volume of 50 µL containing cDNA samples, TaqMan Universal PCR master mix (Applied Biosystems, Foster City, CA). TaqMan glyceraldehyde-3-phosphate dehydrogenase (GAPDH) endogenous control reagent was used as internal control for normalization. Amplification was performed under the following conditions: 50°C for 2 min, 95°C for 10 min, 40 cycles at 95°C for 15 sec, and 60°C for 1 min. Fluorescence in each well was measured using an ABI PRISM 7000 Sequence Detection System. The mRNA expression levels were assessed by relative quantification (RQ). Cycle threshold values for IRGM gene were determined and abundance in comparison to GAPDH was calculated. qRT-PCR results were recorded for IRGM gene as fold change of LPS stimulated vs non-stimulated blood at 4 h using ΔΔC(t) method <xref ref-type="bibr" rid="pone.0091522-Livak1">[22]</xref>. PCR products were evaluated by dissociation curves to confirm single amplicons and the absence of significant primer–dimer contamination.</p>
</sec><sec id="s2f">
<title>6. Statistical Analysis</title>
<p>The Hardy-Weinberg equilibrium for the population distribution of the variant alleles was determined according to the approach described by Guo and Thompson <xref ref-type="bibr" rid="pone.0091522-Guo1">[23]</xref>. Allelic <italic>chi</italic>-squares were examined for each SNP and the correlation/trend test was performed. Odds ratios (ORs) were calculated and <italic>P</italic> values were decided with statistical significance defined by <italic>P</italic>≤0.05 using HelixTree™ software (Golden Helix Inc, Bozeman, MT). We considered the differences significant with respect to mortality at a full scan permutation of the correlation/trend test <italic>P</italic>-value of &lt;0.05. Fold change, or ΔRQ, was calculated to determine the magnitude of difference in gene expression and a Mann-Whitney U test was performed to demonstrate the reproducibility of the changes observed in the IRGM gene after LPS challenge. We compared the variables in different groups using the unpaired Student’s t-test and Mann-Whitney U test, depending on the type of variable. Statistical significance was defined as <italic>P</italic>&lt;0.05. Statistical analyses were performed with the GraphPad Prism 5 software package for Windows (GraphPad Software, CA, USA).</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>1. Baseline Characteristics of Discovery Cohort and Multi-Center Validation Cohort</title>
<p><xref ref-type="table" rid="pone-0091522-t001">Table 1</xref> summarizes the baseline characteristics of the discovery cohort (n = 259) and the multi-center validation cohort (n = 793). No significant difference in age, gender, or length of ICU stay was observed between the two cohorts. In addition, no significant difference in SOFA or APACHE II score was detectable between the two cohorts, which indicated that there was no marked difference in patient backgrounds between the two cohorts. The incidence and mortality rates of severe sepsis/septic shock tended to be greater in the discovery cohort, but the difference was not statistically significant.</p>
<table-wrap id="pone-0091522-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0091522.t001</object-id><label>Table 1</label><caption>
<title>Baseline characteristics of the study population.</title>
</caption><alternatives><graphic id="pone-0091522-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0091522.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="3" align="left" rowspan="1">Discovery cohort</td>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="3" align="left" rowspan="1">Multi-center validation cohort</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">All</td>
<td align="left" rowspan="1" colspan="1">Non-sepsis patients</td>
<td align="left" rowspan="1" colspan="1">SS patients</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic> value</td>
<td align="left" rowspan="1" colspan="1">All</td>
<td align="left" rowspan="1" colspan="1">Non-sepsis patients</td>
<td align="left" rowspan="1" colspan="1">SS patients</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic> value</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">n = 259</td>
<td align="left" rowspan="1" colspan="1">n = 104</td>
<td align="left" rowspan="1" colspan="1">n = 125</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">n = 793</td>
<td align="left" rowspan="1" colspan="1">n = 454</td>
<td align="left" rowspan="1" colspan="1">n = 271</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Age (yaers), mean±SD</td>
<td align="left" rowspan="1" colspan="1">57±17</td>
<td align="left" rowspan="1" colspan="1">57±17</td>
<td align="left" rowspan="1" colspan="1">58±17</td>
<td align="left" rowspan="1" colspan="1">0.492*</td>
<td align="left" rowspan="1" colspan="1">64±17</td>
<td align="left" rowspan="1" colspan="1">62±18</td>
<td align="left" rowspan="1" colspan="1">67±15</td>
<td align="left" rowspan="1" colspan="1">0.0008*</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male/female gender, n</td>
<td align="left" rowspan="1" colspan="1">146/113</td>
<td align="left" rowspan="1" colspan="1">60/44</td>
<td align="left" rowspan="1" colspan="1">69/56</td>
<td align="left" rowspan="1" colspan="1">0.659**</td>
<td align="left" rowspan="1" colspan="1">517/276</td>
<td align="left" rowspan="1" colspan="1">296/158</td>
<td align="left" rowspan="1" colspan="1">176/95</td>
<td align="left" rowspan="1" colspan="1">0.915**</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Length of ICU stay (days), mean±SD</td>
<td align="left" rowspan="1" colspan="1">12.5±17.3</td>
<td align="left" rowspan="1" colspan="1">6.0±7.5</td>
<td align="left" rowspan="1" colspan="1">18.5±22</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001*</td>
<td align="left" rowspan="1" colspan="1">17.3±25</td>
<td align="left" rowspan="1" colspan="1">12.7±17.4</td>
<td align="left" rowspan="1" colspan="1">26.1±34.9</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001*</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">SOFA score, mean±SD</td>
<td align="left" rowspan="1" colspan="1">7.1±5.1</td>
<td align="left" rowspan="1" colspan="1">3.8±3.1</td>
<td align="left" rowspan="1" colspan="1">10.3±4.6</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001*</td>
<td align="left" rowspan="1" colspan="1">6.4±4.4</td>
<td align="left" rowspan="1" colspan="1">4.8±3.5</td>
<td align="left" rowspan="1" colspan="1">9.5±4.2</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001*</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">APACHE II score, mean±SD</td>
<td align="left" rowspan="1" colspan="1">16.4±9.0</td>
<td align="left" rowspan="1" colspan="1">10.6±6.2</td>
<td align="left" rowspan="1" colspan="1">21.9±8.3</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001*</td>
<td align="left" rowspan="1" colspan="1">17.3±8.8</td>
<td align="left" rowspan="1" colspan="1">15.0±8.3</td>
<td align="left" rowspan="1" colspan="1">21.8±7.9</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001*</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Severe sepsis morbidity (%)</td>
<td align="left" rowspan="1" colspan="1">48</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">33.8</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mortality (%)</td>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">5.71</td>
<td align="left" rowspan="1" colspan="1">29.6</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001**</td>
<td align="left" rowspan="1" colspan="1">12.2</td>
<td align="left" rowspan="1" colspan="1">5.4</td>
<td align="left" rowspan="1" colspan="1">25.3</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001**</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Post-surgical operation</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Post-cardiovascular surgery, n(%)</td>
<td align="left" rowspan="1" colspan="1">28 (10.8)</td>
<td align="left" rowspan="1" colspan="1">24 (23.0)</td>
<td align="left" rowspan="1" colspan="1">4 (3.2)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">21 (2.6)</td>
<td align="left" rowspan="1" colspan="1">5 (1.1)</td>
<td align="left" rowspan="1" colspan="1">12 (4.4)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Post-gastrointestinal surgery, n(%)</td>
<td align="left" rowspan="1" colspan="1">33 (12.7)</td>
<td align="left" rowspan="1" colspan="1">11 (10.6)</td>
<td align="left" rowspan="1" colspan="1">15 (12.0)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">79 (10.0)</td>
<td align="left" rowspan="1" colspan="1">25 (5.5)</td>
<td align="left" rowspan="1" colspan="1">43 (15.9)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Others, n(%)</td>
<td align="left" rowspan="1" colspan="1">20 (7.7)</td>
<td align="left" rowspan="1" colspan="1">12 (11.5)</td>
<td align="left" rowspan="1" colspan="1">6 (4.8)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">6 (0.8)</td>
<td align="left" rowspan="1" colspan="1">3 (0.7)</td>
<td align="left" rowspan="1" colspan="1">3 (1.1)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Intracranial disease (ICH/CI), n(%)</td>
<td align="left" rowspan="1" colspan="1">5 (2.0)</td>
<td align="left" rowspan="1" colspan="1">0 (0)</td>
<td align="left" rowspan="1" colspan="1">4 (3.2)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">68 (8.6)</td>
<td align="left" rowspan="1" colspan="1">62 (13.7)</td>
<td align="left" rowspan="1" colspan="1">3 (1.1)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Respiratory failure, n(%)</td>
<td align="left" rowspan="1" colspan="1">28 (10.8)</td>
<td align="left" rowspan="1" colspan="1">4 (3.8)</td>
<td align="left" rowspan="1" colspan="1">22 (17.6)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">77 (9.7)</td>
<td align="left" rowspan="1" colspan="1">15 (3.3)</td>
<td align="left" rowspan="1" colspan="1">51 (18.8)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Heart failure, n(%)</td>
<td align="left" rowspan="1" colspan="1">10 (3.9)</td>
<td align="left" rowspan="1" colspan="1">4 (3.8)</td>
<td align="left" rowspan="1" colspan="1">3 (2.4)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">72 (9.1)</td>
<td align="left" rowspan="1" colspan="1">61 (13.4)</td>
<td align="left" rowspan="1" colspan="1">8 (3.0)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Endogenous abdominal disease</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Acute pancreatitis, n(%)</td>
<td align="left" rowspan="1" colspan="1">22 (8.5)</td>
<td align="left" rowspan="1" colspan="1">16 (15.4)</td>
<td align="left" rowspan="1" colspan="1">6 (4.8)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">39 (4.9)</td>
<td align="left" rowspan="1" colspan="1">22 (4.8)</td>
<td align="left" rowspan="1" colspan="1">14 (5.2)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Gastrointestinal bleeding, n(%)</td>
<td align="left" rowspan="1" colspan="1">5 (2.0)</td>
<td align="left" rowspan="1" colspan="1">2 (1.9)</td>
<td align="left" rowspan="1" colspan="1">3 (2.4)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">36 (4.5)</td>
<td align="left" rowspan="1" colspan="1">33 (7.3)</td>
<td align="left" rowspan="1" colspan="1">2 (0.7)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hepatic failure, n(%)</td>
<td align="left" rowspan="1" colspan="1">7 (2.7)</td>
<td align="left" rowspan="1" colspan="1">3 (2.9)</td>
<td align="left" rowspan="1" colspan="1">4 (3.2)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">19 (2.4)</td>
<td align="left" rowspan="1" colspan="1">7 (1.5)</td>
<td align="left" rowspan="1" colspan="1">9 (3.3)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Others, n(%)</td>
<td align="left" rowspan="1" colspan="1">13 (5.0)</td>
<td align="left" rowspan="1" colspan="1">1 (1.0)</td>
<td align="left" rowspan="1" colspan="1">9 (7.2)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">34 (4.3)</td>
<td align="left" rowspan="1" colspan="1">10 (2.2)</td>
<td align="left" rowspan="1" colspan="1">21 (7.7)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CPAOA, n(%)</td>
<td align="left" rowspan="1" colspan="1">4 (1.5)</td>
<td align="left" rowspan="1" colspan="1">2 (1.9)</td>
<td align="left" rowspan="1" colspan="1">2 (1.6)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">39 (4.9)</td>
<td align="left" rowspan="1" colspan="1">32 (7.0)</td>
<td align="left" rowspan="1" colspan="1">4 (1.5)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Trauma, n(%)</td>
<td align="left" rowspan="1" colspan="1">11 (4.3)</td>
<td align="left" rowspan="1" colspan="1">9 (8.7)</td>
<td align="left" rowspan="1" colspan="1">0 (0)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">119 (15.0)</td>
<td align="left" rowspan="1" colspan="1">105 (23.1)</td>
<td align="left" rowspan="1" colspan="1">8 (3.0)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Intoxication, n(%)</td>
<td align="left" rowspan="1" colspan="1">8 (3.1)</td>
<td align="left" rowspan="1" colspan="1">4 (3.8)</td>
<td align="left" rowspan="1" colspan="1">4 (3.2)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">23 (2.9)</td>
<td align="left" rowspan="1" colspan="1">17 (3.7)</td>
<td align="left" rowspan="1" colspan="1">6 (2.2)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Burn, n(%)</td>
<td align="left" rowspan="1" colspan="1">2 (0.8)</td>
<td align="left" rowspan="1" colspan="1">1 (1.0)</td>
<td align="left" rowspan="1" colspan="1">0 (0)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">12 (1.5)</td>
<td align="left" rowspan="1" colspan="1">7 (1.5)</td>
<td align="left" rowspan="1" colspan="1">4 (1.5)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Others, n(%)</td>
<td align="left" rowspan="1" colspan="1">63 (24.3)</td>
<td align="left" rowspan="1" colspan="1">11 (10.6)</td>
<td align="left" rowspan="1" colspan="1">43 (34.4)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">149 (18.8)</td>
<td align="left" rowspan="1" colspan="1">50 (11.0)</td>
<td align="left" rowspan="1" colspan="1">83 (30.6)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p><italic>P</italic> values were calculated with Student’s t-test* and Fisher’s exact test**. SS, severe sepsis/septic shock; ICU, intensive care unit; SOFA, sequential organ failure assessment; APACHE II, the acute physiology and chronic health evaluation; ICH, intracerebral hemorrhage; CI, cerebral infarction; CPAOA, cardiopulmonary arrest on arrival; SD, standard deviation.</p></fn></table-wrap-foot></table-wrap>
<p>For the comparison of patient backgrounds, patients with severe sepsis/septic shock in each of the two cohorts were further divided into two categories based on IRGM(+313) (rs10065172) genotype: CC+CT and TT (<xref ref-type="table" rid="pone-0091522-t002">Table 2</xref>). No significant difference in age, gender, length of ICU stay, or SOFA score was observed between the two genotype categories in either cohort. A significant difference in APACHE II score between genotype categories was observed only in the discovery cohort: TT homozygotes exhibited a significantly higher APACHE II score than CC+CT genotypes (26.5±8.1 vs. 21.3±8.1, <italic>P = </italic>0.031).</p>
<table-wrap id="pone-0091522-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0091522.t002</object-id><label>Table 2</label><caption>
<title>Severe sepsis/septic shock (SS) patient’s baseline characteristics with regard to IRGM(+313) (rs10065172) genotypes.</title>
</caption><alternatives><graphic id="pone-0091522-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0091522.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="2" align="left" rowspan="1">Discovery cohort</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="3" align="left" rowspan="1">Multi-center validation cohort</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">All</td>
<td align="left" rowspan="1" colspan="1">CC+CT</td>
<td align="left" rowspan="1" colspan="1">TT</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic> value</td>
<td align="left" rowspan="1" colspan="1">All</td>
<td align="left" rowspan="1" colspan="1">CC+CT</td>
<td align="left" rowspan="1" colspan="1">TT</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic> value</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(n = 125)</td>
<td align="left" rowspan="1" colspan="1">(n = 112)</td>
<td align="left" rowspan="1" colspan="1">(n = 13)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">(n = 268)</td>
<td align="left" rowspan="1" colspan="1">(n = 242)</td>
<td align="left" rowspan="1" colspan="1">(n = 26)</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Age (years), mean±SD</td>
<td align="left" rowspan="1" colspan="1">57±17</td>
<td align="left" rowspan="1" colspan="1">56.7±17.3</td>
<td align="left" rowspan="1" colspan="1">65.1±14.4</td>
<td align="left" rowspan="1" colspan="1">0.097*</td>
<td align="left" rowspan="1" colspan="1">66±15</td>
<td align="left" rowspan="1" colspan="1">67±15</td>
<td align="left" rowspan="1" colspan="1">67±15.3</td>
<td align="left" rowspan="1" colspan="1">0.861*</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Male/female gender, n</td>
<td align="left" rowspan="1" colspan="1">69/56</td>
<td align="left" rowspan="1" colspan="1">61/51</td>
<td align="left" rowspan="1" colspan="1">8/5</td>
<td align="left" rowspan="1" colspan="1">0.771**</td>
<td align="left" rowspan="1" colspan="1">173/95</td>
<td align="left" rowspan="1" colspan="1">155/87</td>
<td align="left" rowspan="1" colspan="1">18/8</td>
<td align="left" rowspan="1" colspan="1">0.671**</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Length of ICU stay (days), mean±SD</td>
<td align="left" rowspan="1" colspan="1">18.4±22.0</td>
<td align="left" rowspan="1" colspan="1">19.2±22.9</td>
<td align="left" rowspan="1" colspan="1">11.7±8.8</td>
<td align="left" rowspan="1" colspan="1">0.243*</td>
<td align="left" rowspan="1" colspan="1">26.3±35</td>
<td align="left" rowspan="1" colspan="1">26.3±35.7</td>
<td align="left" rowspan="1" colspan="1">24.6±26</td>
<td align="left" rowspan="1" colspan="1">0.811*</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">SOFA score, mean±SD</td>
<td align="left" rowspan="1" colspan="1">10.3±4.6</td>
<td align="left" rowspan="1" colspan="1">10.0±4.5</td>
<td align="left" rowspan="1" colspan="1">12.5±5.1</td>
<td align="left" rowspan="1" colspan="1">0.076*</td>
<td align="left" rowspan="1" colspan="1">9.4±4.2</td>
<td align="left" rowspan="1" colspan="1">9.4±4.2</td>
<td align="left" rowspan="1" colspan="1">10.8±4.1</td>
<td align="left" rowspan="1" colspan="1">0.094*</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">APACHE II score, mean±SD</td>
<td align="left" rowspan="1" colspan="1">21.9±8.3</td>
<td align="left" rowspan="1" colspan="1">21.3±8.1</td>
<td align="left" rowspan="1" colspan="1">26.5±8.1</td>
<td align="left" rowspan="1" colspan="1">0.031*</td>
<td align="left" rowspan="1" colspan="1">21.8±8.0</td>
<td align="left" rowspan="1" colspan="1">21.9±7.9</td>
<td align="left" rowspan="1" colspan="1">21.4±8.4</td>
<td align="left" rowspan="1" colspan="1">0.758*</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mortality (%)</td>
<td align="left" rowspan="1" colspan="1">29.6</td>
<td align="left" rowspan="1" colspan="1">26.8</td>
<td align="left" rowspan="1" colspan="1">53.8</td>
<td align="left" rowspan="1" colspan="1">0.043<sup>#</sup></td>
<td align="left" rowspan="1" colspan="1">25.4</td>
<td align="left" rowspan="1" colspan="1">23.6</td>
<td align="left" rowspan="1" colspan="1">42.3</td>
<td align="left" rowspan="1" colspan="1">0.037<sup>#</sup></td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt102"><label/><p><italic>P</italic> values were calculated with Student’s t-test*, Fisher’s exact test**, and correlation/trend test<sup>#</sup>. SS, severe sepsis/septic shock; ICU, intensive care unit; SOFA, sequential organ failure assessment; APACHE II, the acute physiology and chronic health evaluation; SD, standard deviation.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b">
<title>2. Genotype Distributions</title>
<p><xref ref-type="table" rid="pone-0091522-t003">Table 3</xref> summarizes the genotype distributions in all subjects of the present study. The subjects were divided into three groups (severe sepsis/septic shock (SS), non-sepsis, and healthy volunteers) for comparison of distribution of the three genotypes (CC, CT, and TT). The genotypic distribution in IRGM(+313) did not diverge from Hardy-Weinberg equilibrium in all the three studied groups. As shown in <xref ref-type="table" rid="pone-0091522-t003">Table 3</xref>, no apparent difference in the percentages of the CC/CT/TT genotypes was observed among the three groups.</p>
<table-wrap id="pone-0091522-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0091522.t003</object-id><label>Table 3</label><caption>
<title>Genotype distributions.</title>
</caption><alternatives><graphic id="pone-0091522-t003-3" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0091522.t003" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">IRGM(+313) genotypes</td>
<td align="left" rowspan="1" colspan="1">SS patients</td>
<td align="left" rowspan="1" colspan="1">Non-sepsis patients</td>
<td align="left" rowspan="1" colspan="1">Healthy volunteers</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">n (%)</td>
<td align="left" rowspan="1" colspan="1">n (%)</td>
<td align="left" rowspan="1" colspan="1">n (%)</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">CC</td>
<td align="left" rowspan="1" colspan="1">164 (41.7)</td>
<td align="left" rowspan="1" colspan="1">242 (43.7)</td>
<td align="left" rowspan="1" colspan="1">144 (41.5)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CT</td>
<td align="left" rowspan="1" colspan="1">190 (48.3)</td>
<td align="left" rowspan="1" colspan="1">245 (44.3)</td>
<td align="left" rowspan="1" colspan="1">163 (47.0)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">TT</td>
<td align="left" rowspan="1" colspan="1">39 (9.92)</td>
<td align="left" rowspan="1" colspan="1">66 (11.9)</td>
<td align="left" rowspan="1" colspan="1">40 (11.5)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hardy-Weinberg equilibrium test <italic>P</italic> value</td>
<td align="left" rowspan="1" colspan="1">0.133</td>
<td align="left" rowspan="1" colspan="1">0.741</td>
<td align="left" rowspan="1" colspan="1">0.549</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt103"><label/><p>SS, severe sepsis/septic shock.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3c">
<title>3. Comparison of Mortality Rate</title>
<p>For both of the cohorts, the mortality rate was compared between two different genotype categories separately within the non-sepsis and SS groups. For the discovery cohort, no significant difference in mortality was observed between the CC+CT genotype and TT homozygotes in the non-sepsis group, while TT homozygotes exhibited a significantly higher mortality rate than the CC+CT genotype in the SS group (<italic>P = </italic>0.043) (Table2, <xref ref-type="fig" rid="pone-0091522-g001">Fig. 1a</xref>). Similar results were obtained for the multi-center validation cohort (<italic>P = </italic>0.037) (Table2, <xref ref-type="fig" rid="pone-0091522-g001">Fig. 1b</xref>).</p>
<fig id="pone-0091522-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0091522.g001</object-id><label>Figure 1</label><caption>
<title>Comparison of mortality between different genotype categories for SNP at IRGM(+313) (rs10065172).</title>
<p>(a) The discovery cohort (<italic>P</italic> = 0.043, recessive model of the correlation/trend test; TT v (CC+CT) in the 125 SS patients). (b) The multi-center validation cohort (<italic>P</italic> = 0.037, recessive model the correlation/trend test; TT v (CC+CT) in the 271 SS patients). (c) The combined cohort (<italic>P</italic> = 0.004, recessive model the correlation/trend test; TT v (CC+CT) in the 396 SS patients). SS, severe sepsis/septic shock.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0091522.g001" position="float" xlink:type="simple"/></fig>
<p>When the two cohorts were combined and analyzed in a similar manner for validation, the statistical significance of the difference in mortality rate between the two genotype categories was even greater (<italic>P = </italic>0.004) (<xref ref-type="fig" rid="pone-0091522-g001">Fig. 1c</xref>). The model treating the C allele as dominant, which combines the CC and CT genotypes into one category, provides the smallest <italic>P</italic> value of all the association tests (<xref ref-type="table" rid="pone-0091522-t004">Table 4</xref>). That is the reason why we performed the further analysis on mRNA expression by comparing TT and CC+CT genotypes.</p>
<table-wrap id="pone-0091522-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0091522.t004</object-id><label>Table 4</label><caption>
<title>Tests of association between IRGM(+313) genotype and severe sepsis death in the combined cohort.</title>
</caption><alternatives><graphic id="pone-0091522-t004-4" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0091522.t004" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td colspan="3" align="left" rowspan="1">Genotype</td>
<td align="left" rowspan="1" colspan="1"><italic>P</italic> value</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">CC</td>
<td align="left" rowspan="1" colspan="1">CT</td>
<td align="left" rowspan="1" colspan="1">TT</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Additive model OR (vs CC)</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">0.86</td>
<td align="left" rowspan="1" colspan="1">2.82</td>
<td align="left" rowspan="1" colspan="1">0.126</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dominant T allele OR (vs CC)</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">1.06</td>
<td align="left" rowspan="1" colspan="1">1.06</td>
<td align="left" rowspan="1" colspan="1">0.803</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dominant C allele OR (vs CC+CT)</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">2.63</td>
<td align="left" rowspan="1" colspan="1">0.004</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Allele table, T vs C allele</td>
<td align="left" rowspan="1" colspan="1">1(C)</td>
<td align="left" rowspan="1" colspan="1">1.28(T)</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">0.141</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt104"><label/><p><italic>P</italic> values were calculated with correlation/trend test.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3d">
<title>4. <italic>Ex vivo</italic> LPS Challenge and mRNA Assay</title>
<p>The genotype distribution in the healthy volunteer group (n = 347) was not apparently different from that in either the SS group or the non-sepsis group (<xref ref-type="table" rid="pone-0091522-t003">Table 3</xref>). When <italic>ex vivo</italic> LPS challenge and mRNA assays were performed for 70 subjects in the healthy volunteer group, the mean ΔRQ for the TT homozygotes (−0.3465, SD = 0.1133) was significantly lower than the values for the CC homozygote (1.427, SD = 0.5809) and the CT heterozygote (0.6702, SD = 0.1702) (<italic>P = </italic>0.019) (<xref ref-type="table" rid="pone-0091522-t005">Table 5</xref>).</p>
<table-wrap id="pone-0091522-t005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0091522.t005</object-id><label>Table 5</label><caption>
<title>IRGM(+313) mRNA expression of whole blood with LPS challenge in healthy volunteers.</title>
</caption><alternatives><graphic id="pone-0091522-t005-5" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0091522.t005" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">IRGM(+313) genotypes</td>
<td align="left" rowspan="1" colspan="1">CC</td>
<td align="left" rowspan="1" colspan="1">CT</td>
<td align="left" rowspan="1" colspan="1">TT</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">(n = 70)</td>
<td align="left" rowspan="1" colspan="1">(n = 33)</td>
<td align="left" rowspan="1" colspan="1">(n = 33)</td>
<td align="left" rowspan="1" colspan="1">(n = 4)</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Mean ΔRQ</td>
<td align="left" rowspan="1" colspan="1">1.427</td>
<td align="left" rowspan="1" colspan="1">0.6702</td>
<td align="left" rowspan="1" colspan="1">−0.3465</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Std. Error</td>
<td align="left" rowspan="1" colspan="1">0.5809</td>
<td align="left" rowspan="1" colspan="1">0.1702</td>
<td align="left" rowspan="1" colspan="1">0.1133</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt105"><label/><p><italic>P</italic> = 0.019 with Mann-Whitney U test ((CC+CT) v TT).</p></fn><fn id="nt106"><label/><p>RQ, relative quantification; ΔRQ, (post-stimulation)-(pre-stimulation with LPS).</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s4">
<title>Discussion</title>
<p>As described above, we demonstrated that TT homozygosity at the IRGM(+313) (rs10065172) SNP locus, an autophagy-related genetic polymorphism, was associated with a significantly higher mortality rate in SS group patients in two cohorts, a single-center cohort and a multi-center cohort. When the two cohorts were combined and analyzed in a similar manner for validation, the statistical significance of the difference in mortality rate between TT homozygotes and the CC+CT genotype category was even greater. In addition, when whole blood was exposed to stimulus by LPS and <italic>IRGM</italic> mRNA expression was assayed, the amount of mRNA expressed was significantly lower in the TT homozygotes.</p>
<p>The development of organ dysfunction in severe sepsis may be ascribable to the dysfunction or death of cells constituting the deteriorated organ <xref ref-type="bibr" rid="pone.0091522-Oda1">[13]</xref>. While cell death induced by cellular dysfunction has traditionally been interpreted as the result of necrosis, a different type of cell death, apoptosis, was identified as an additional mechanism of cell death in sepsis, depending on the cell type <xref ref-type="bibr" rid="pone.0091522-Hotchkiss4">[24]</xref>. Apoptosis is a mechanism of regulated suicide of cells, <italic>i.e.</italic>, programmed cell death, triggered to protect an individual. In addition to necrosis and apoptosis, autophagy has recently been highlighted as a third mechanism of cell death <xref ref-type="bibr" rid="pone.0091522-Hotchkiss2">[7]</xref>.</p>
<p>Autophagy is a physiological phenomenon of “self-eating” that involves self-degradation of proteins by cells experiencing unfavorable conditions for survival, such as a poor nutritional environment, <italic>i.e.</italic> starvation. Autophagy contributes to the maintenance of biological homeostasis by recycling proteins and eliminating pathogenic microorganisms that invade the cytoplasm <xref ref-type="bibr" rid="pone.0091522-Choi1">[12]</xref>. When cells are starved, protein synthesis slows down. Autophagy occurs in such a situation to enable cells to transfer their own amino acids to other cells. During the process of autophagy, cell organelles are incorporated into autophagosomes, which fuse with lysozomes for intracellular digestion. Which cells fall into necrosis, apoptosis, or autophagy under a highly invasive condition such as sepsis remains controversial <xref ref-type="bibr" rid="pone.0091522-Hotchkiss2">[7]</xref>, <xref ref-type="bibr" rid="pone.0091522-Crouser1">[9]</xref>, <xref ref-type="bibr" rid="pone.0091522-Watanabe1">[11]</xref>, <xref ref-type="bibr" rid="pone.0091522-Hsieh2">[25]</xref>–<xref ref-type="bibr" rid="pone.0091522-Medzhitov1">[27]</xref>.</p>
<p>Autophagy has been reported in a number of cases of sepsis. Crouser et al. <xref ref-type="bibr" rid="pone.0091522-Crouser1">[9]</xref> implicated mitochondrial depletion is related to the removal of damaged mitochondria by autophagy during mouse cecal ligation and puncture (CLP) model of sepsis. Watanabe et al. <xref ref-type="bibr" rid="pone.0091522-Watanabe1">[11]</xref> observed increased numbers of autophagosomes in the liver cells of patients with severe sepsis and further demonstrated increased numbers of autophagosomes in the liver of a mouse CLP model. Using the same animal model of sepsis in GFP-LC3 transgenic mice, Takahashi et al. <xref ref-type="bibr" rid="pone.0091522-Takahashi1">[28]</xref> demonstrated a transient increase in autophagic activity during the acute phase of sepsis with subsequent stagnation of autophagic flux. While the relationship between autophagy and sepsis is beginning to be clarified, the details of their association remain unknown.</p>
<p>IRGM was originally identified as a molecule with an important function in eliminating <italic>Mycobacterium tuberculosis</italic> from the host cell via autophagy <xref ref-type="bibr" rid="pone.0091522-Gutierrez1">[29]</xref>. We believe the present work has major implication for the broader field of sepsis because of the similarities between active tuberculosis and proacted sepsis. The possible involvement of <italic>IRGM</italic> polymorphism in the development of Crohn’s disease, an inflammatory bowel disease, has been reported. Work by Brest et al. <xref ref-type="bibr" rid="pone.0091522-Brest1">[30]</xref> implicated a variant at the IRGM(+313) locus in the activity of infection control in the intestinal epithelia of individuals with Crohn’s disease. They demonstrated that a family of microRNAs overexpressed under inflammatory conditions formed a complex with <italic>IRGM</italic> mRNA to regulate IRGM production.</p>
<p><italic>IRGM</italic> polymorphism has also been reported to be involved in mitochondrial dysfunction. Singh et al. <xref ref-type="bibr" rid="pone.0091522-Singh2">[31]</xref> showed that IRGM translocates to the mitochondrial inner membrane to regulate mitochondrial nuclear fission. They also reported that the overexpression of a particular IRGM isoform caused mitochondrial nuclear fission and depolarization as well as autophagy-independent cell death. Furthermore, Carre et al. <xref ref-type="bibr" rid="pone.0091522-Carr1">[32]</xref> reported that the activation of mitochondrial biogenesis in the skeletal muscle of septic patients contributed to a favorable outcome. Watanabe et al. <xref ref-type="bibr" rid="pone.0091522-Watanabe1">[11]</xref> reported that liver cells from patients with sepsis had both a reproducible pattern of mitochondrial injury and a marked increase in autophagic vacuolization. Takasu et al. <xref ref-type="bibr" rid="pone.0091522-Takasu1">[26]</xref> identified mitochondrial membrane injury and autophagosome formation in renal proximal tubules of septic patients.</p>
<p>Autophagy and organ failure have recently gained attention in the field of surgical nutrition. Vanhorebeek et al. <xref ref-type="bibr" rid="pone.0091522-Vanhorebeek1">[33]</xref> have reported that a relatively fasted state is required for proper functioning of autophagy in nutrition support during the first days of critical illness. Early overfeeding under a highly invasive condition might lead to the insufficient activation of autophagy. This would lead to susceptibility to infections resulting from defects in host defense mechanisms as well as abnormal activity of the cellular injury repair system. Consequently, the accumulation of various injuries at the cellular level would induce organ dysfunction and delay recovery. These undesirable factors would ultimately affect each other. We hypothesized that the ‘physiologic’ autophagy flux is disturbed in severely septic conditions and this impaired autophagy causes the patient deterioration through tissue dysoxia. The less expresser in <italic>IRGM</italic> SNP, <italic>i.e.</italic>, TT homozygotes of IRGM(+313), might cause the harmful effect in the pathophysiology of severe sepsis/septic shock.</p>
<p>The present study has the following limitations: First, the pathogen for sepsis was identified in only a limited number of septic patients included in the study. Although the mechanisms of autophagy against different pathogenic microorganisms such as <italic>Mycobacterium tuberculosis</italic>, <italic>Listeria</italic>, and <italic>Toxoplasma</italic> are being clarified separately, the pathogen was unknown in the majority of our septic patients. Consequently, the mechanism of autophagy in each septic patient also remains unknown and must be discussed only with respect to sepsis in general.</p>
<p>Second, the patients studied were admitted to the participating centers over a period of 12 years although they were included without any overlaps. The standard treatment for severe sepsis/septic shock might not be identical throughout such a long study period, and the possible influence of treatment variation on clinical outcome of the patients cannot be ruled out. Third, the <italic>IRGM</italic> and the gene product might be associated with the role of autophagy in bacterial processing, however data that correlates this with bacterial clearance has not been demonstrated. We speculate that this impaired autophagic response that is altered by the TT homozygote lead to decreased <italic>IRGM</italic> expression, hampered the autophagic function of limiting cellular and organ injury <xref ref-type="bibr" rid="pone.0091522-Carchman1">[34]</xref>. Finally, the concentration of LPS used in LPS challenge of whole blood collected from healthy humans (final concentration, 1 ng/mL) was much higher than that used for LPS challenge in animal studies. Regardless of the limitation, a significant suppression of IRGM gene expression at the mRNA level in TT variant homozygotes in response to LPS in human whole blood cells was observed for the first time in this study. The assay of <italic>IRGM</italic> mRNA in blood collected from patients with severe sepsis for comparison among different genetic variants may be of significance in elucidating the genetic mechanisms regulating autophagy. However, this approach may not always be easy, since the expression of various genes related to the inflammatory response is known to change during the clinical course of sepsis and vary depending on the etiology <xref ref-type="bibr" rid="pone.0091522-Xiao1">[35]</xref>.</p>
</sec><sec id="s5">
<title>Conclusions</title>
<p>In the present single-center and multi-center study, we demonstrated that TT homozygosity at the IRGM(+313) locus, an autophagy-related polymorphic locus, affected clinical outcome in patients with severe sepsis. LPS challenge of whole blood from healthy volunteers showed significantly reduced expression of <italic>IRGM</italic> in TT homozygotes. The present study suggests the possibility that TT homozygosity at the IRGM(+313) locus may be involved in the suppression of <italic>IRGM</italic> expression in severe sepsis, thereby suppressing autophagy and leading to a poor clinical outcome.</p>
</sec></body>
<back>
<ack>
<p>The authors thank Mrs. Ayako Teratani and Mrs. Miyako Maganuma for their excellent technical assistance, and Ms. Yoshiko Ohashi for her excellent secretarial assistance.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0091522-Vincent1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vincent</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Opal</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Marshall</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Tracey</surname><given-names>KJ</given-names></name> (<year>2013</year>) <article-title>Sepsis definitions: time for change</article-title>. <source>Lancet</source> <volume>381</volume>: <fpage>774</fpage>–<lpage>775</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Beale1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Beale</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Reinhart</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Brunkhorst</surname><given-names>FM</given-names></name>, <name name-style="western"><surname>Dobb</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Levy</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry</article-title>. <source>Infection</source> <volume>37</volume>: <fpage>222</fpage>–<lpage>232</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Silva1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Silva</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Cavalcanti</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Bugano</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>Janes</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Vallet</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Do established prognostic factors explain the different mortality rates in ICU septic patients around the world?</article-title> <source>Minerva Anestesiol</source> <volume>78</volume>: <fpage>1215</fpage>–<lpage>1225</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Hotchkiss1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hotchkiss</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Karl</surname><given-names>IE</given-names></name> (<year>2003</year>) <article-title>The pathophysiology and treatment of sepsis</article-title>. <source>N Engl J Med</source> <volume>348</volume>: <fpage>138</fpage>–<lpage>150</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Frazier1"><label>5</label>
<mixed-citation publication-type="other" xlink:type="simple">Frazier WJ, Hall MW (2008) Immunoparalysis and adverse outcomes from critical illness. Pediatr Clin North Am 55: 647–668, xi.</mixed-citation>
</ref>
<ref id="pone.0091522-Boomer1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boomer</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>To</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Takasu</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Osborne</surname><given-names>DF</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Immunosuppression in patients who die of sepsis and multiple organ failure</article-title>. <source>JAMA</source> <volume>306</volume>: <fpage>2594</fpage>–<lpage>2605</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Hotchkiss2"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hotchkiss</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Strasser</surname><given-names>A</given-names></name>, <name name-style="western"><surname>McDunn</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Swanson</surname><given-names>PE</given-names></name> (<year>2009</year>) <article-title>Cell death</article-title>. <source>N Engl J Med</source> <volume>361</volume>: <fpage>1570</fpage>–<lpage>1583</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Hotchkiss3"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hotchkiss</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Monneret</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Payen</surname><given-names>D</given-names></name> (<year>2013</year>) <article-title>Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy</article-title>. <source>Nat Rev Immunol</source> <volume>13</volume>: <fpage>862</fpage>–<lpage>874</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Crouser1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Crouser</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Julian</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Huff</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Struck</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cook</surname><given-names>CH</given-names></name> (<year>2006</year>) <article-title>Carbamoyl phosphate synthase-1: a marker of mitochondrial damage and depletion in the liver during sepsis</article-title>. <source>Crit Care Med</source> <volume>34</volume>: <fpage>2439</fpage>–<lpage>2446</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Hsieh1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hsieh</surname><given-names>YC</given-names></name>, <name name-style="western"><surname>Athar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chaudry</surname><given-names>IH</given-names></name> (<year>2009</year>) <article-title>When apoptosis meets autophagy: deciding cell fate after trauma and sepsis</article-title>. <source>Trends Mol Med</source> <volume>15</volume>: <fpage>129</fpage>–<lpage>138</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Watanabe1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Watanabe</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Muenzer</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Hawkins</surname><given-names>WG</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>CG</given-names></name>, <name name-style="western"><surname>Dixon</surname><given-names>DJ</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Sepsis induces extensive autophagic vacuolization in hepatocytes: a clinical and laboratory-based study</article-title>. <source>Lab Invest</source> <volume>89</volume>: <fpage>549</fpage>–<lpage>561</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Choi1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Choi</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Ryter</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Levine</surname><given-names>B</given-names></name> (<year>2013</year>) <article-title>Autophagy in human health and disease</article-title>. <source>N Engl J Med</source> <volume>368</volume>: <fpage>651</fpage>–<lpage>662</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Oda1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Oda</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hirasawa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sugai</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Shiga</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Nakanishi</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Comparison of Sepsis-related Organ Failure Assessment (SOFA) score and CIS (cellular injury score) for scoring of severity for patients with multiple organ dysfunction syndrome (MODS)</article-title>. <source>Intensive Care Med</source> <volume>26</volume>: <fpage>1786</fpage>–<lpage>1793</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Hampe1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hampe</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Franke</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rosenstiel</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Till</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Teuber</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1</article-title>. <source>Nat Genet</source> <volume>39</volume>: <fpage>207</fpage>–<lpage>211</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Singh1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Singh</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Deretic</surname><given-names>V</given-names></name> (<year>2006</year>) <article-title>Human IRGM induces autophagy to eliminate intracellular mycobacteria</article-title>. <source>Science</source> <volume>313</volume>: <fpage>1438</fpage>–<lpage>1441</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Amre1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Amre</surname><given-names>DK</given-names></name>, <name name-style="western"><surname>Mack</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Morgan</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Krupoves</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Costea</surname><given-names>I</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Autophagy gene ATG16L1 but not IRGM is associated with Crohn’s disease in Canadian children</article-title>. <source>Inflamm Bowel Dis</source> <volume>15</volume>: <fpage>501</fpage>–<lpage>507</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Vincent2"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vincent</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>de Mendonça</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cantraine</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Moreno</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Takala</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine</article-title>. <source>Crit Care Med</source> <volume>26</volume>: <fpage>1793</fpage>–<lpage>1800</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Knaus1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Knaus</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Draper</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Wagner</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Zimmerman</surname><given-names>JE</given-names></name> (<year>1985</year>) <article-title>APACHE II: a severity of disease classification system</article-title>. <source>Crit Care Med</source> <volume>13</volume>: <fpage>818</fpage>–<lpage>829</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><article-title>American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis</article-title>. <source>Crit Care Med</source> <volume>20</volume>: <fpage>864</fpage>–<lpage>874</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Parkes1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Parkes</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Barrett</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Prescott</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Tremelling</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>CA</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn’s disease susceptibility</article-title>. <source>Nat Genet</source> <volume>39</volume>: <fpage>830</fpage>–<lpage>832</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Prescott1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Prescott</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Dominy</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Kubo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lewis</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Fisher</surname><given-names>SA</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Independent and population-specific association of risk variants at the IRGM locus with Crohn’s disease</article-title>. <source>Hum Mol Genet</source> <volume>19</volume>: <fpage>1828</fpage>–<lpage>1839</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Livak1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Livak</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Schmittgen</surname><given-names>TD</given-names></name> (<year>2001</year>) <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method</article-title>. <source>Methods</source> <volume>25</volume>: <fpage>402</fpage>–<lpage>408</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Guo1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guo</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>EA</given-names></name> (<year>1992</year>) <article-title>Performing the exact test of Hardy-Weinberg proportion for multiple alleles</article-title>. <source>Biometrics</source> <volume>48</volume>: <fpage>361</fpage>–<lpage>372</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Hotchkiss4"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hotchkiss</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Swanson</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>Cobb</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Jacobson</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Buchman</surname><given-names>TG</given-names></name>, <etal>et al</etal>. (<year>1997</year>) <article-title>Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice</article-title>. <source>Crit Care Med</source> <volume>25</volume>: <fpage>1298</fpage>–<lpage>1307</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Hsieh2"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hsieh</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Pai</surname><given-names>PY</given-names></name>, <name name-style="western"><surname>Hsueh</surname><given-names>HW</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Hsieh</surname><given-names>YC</given-names></name> (<year>2011</year>) <article-title>Complete induction of autophagy is essential for cardioprotection in sepsis</article-title>. <source>Ann Surg</source> <volume>253</volume>: <fpage>1190</fpage>–<lpage>1200</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Takasu1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Takasu</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Gaut</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Watanabe</surname><given-names>E</given-names></name>, <name name-style="western"><surname>To</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Fagley</surname><given-names>RE</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Mechanisms of cardiac and renal dysfunction in patients dying of sepsis</article-title>. <source>Am J Respir Crit Care Med</source> <volume>187</volume>: <fpage>509</fpage>–<lpage>517</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Medzhitov1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Medzhitov</surname><given-names>R</given-names></name> (<year>2013</year>) <article-title>Septic shock: on the importance of being tolerant</article-title>. <source>Immunity</source> <volume>39</volume>: <fpage>799</fpage>–<lpage>800</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Takahashi1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Takahashi</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Watanabe</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Fujimura</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Watanabe-Takano</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yoshidome</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Kinetics and protective role of autophagy in a mouse cecal ligation and puncture-induced sepsis</article-title>. <source>Crit Care</source> <volume>17</volume>: <fpage>R160</fpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Gutierrez1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gutierrez</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Master</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Colombo</surname><given-names>MI</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages</article-title>. <source>Cell</source> <volume>119</volume>: <fpage>753</fpage>–<lpage>766</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Brest1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brest</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Lapaquette</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Souidi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lebrigand</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Cesaro</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn’s disease</article-title>. <source>Nat Genet</source> <volume>43</volume>: <fpage>242</fpage>–<lpage>245</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Singh2"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Singh</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Ornatowski</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Vergne</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Naylor</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Delgado</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Human IRGM regulates autophagy and cell-autonomous immunity functions through mitochondria</article-title>. <source>Nat Cell Biol</source> <volume>12</volume>: <fpage>1154</fpage>–<lpage>1165</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Carr1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Carré</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Orban</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Re</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Felsmann</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Iffert</surname><given-names>W</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Survival in critical illness is associated with early activation of mitochondrial biogenesis</article-title>. <source>Am J Respir Crit Care Med</source> <volume>182</volume>: <fpage>745</fpage>–<lpage>751</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Vanhorebeek1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vanhorebeek</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Gunst</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Derde</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Derese</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Boussemaere</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Insufficient activation of autophagy allows cellular damage to accumulate in critically ill patients</article-title>. <source>J Clin Endocrinol Metab</source> <volume>96</volume>: <fpage>E633</fpage>–<lpage>645</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Carchman1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Carchman</surname><given-names>EH</given-names></name>, <name name-style="western"><surname>Rao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Loughran</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Rosengart</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Zuckerbraun</surname><given-names>BS</given-names></name> (<year>2011</year>) <article-title>Heme oxygenase-1-mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice</article-title>. <source>Hepatology</source> <volume>53</volume>: <fpage>2053</fpage>–<lpage>2062</lpage>.</mixed-citation>
</ref>
<ref id="pone.0091522-Xiao1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xiao</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Mindrinos</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Seok</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cuschieri</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cuenca</surname><given-names>AG</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>A genomic storm in critically injured humans</article-title>. <source>J Exp Med</source> <volume>208</volume>: <fpage>2581</fpage>–<lpage>2590</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>